Naproxen

Product NDC: 51655-457
11-digit product format: 516550457
Labeler code: 51655
Product ID: 51655-457_49edbcc6-3934-c4fa-e063-6294a90a3e48
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Naproxen
Dosage form: TABLET
Route: ORAL
Labeler: Northwind Health Company, LLC
Application: ANDA074140
Marketing category: ANDA
Marketing start: 2023-05-04
Substance: NAPROXEN
Active strength: 500 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 35 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51655-457-26	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51655-457-25	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51655-457-52	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51655-457-20	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51655-457-26	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51655-457-25	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51655-457-52	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51655-457-20	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51655-457-26	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51655-457-25	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51655-457-52	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51655-457-20	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51655-457-26	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51655-457-25	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51655-457-52	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51655-457-20	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51655-457-52	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51655-457-25	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51655-457-26	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51655-457-20	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51655-457-52	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51655-457-25	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51655-457-26	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51655-457-20	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51655-457-52	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51655-457-25	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51655-457-26	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51655-457-20	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A074140-001	NAPROXEN	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21
A074140-002	NAPROXEN	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21
A074140-003	NAPROXEN	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A074140-001	AB
A074140-002	AB
A074140-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074140-002	NAPROXEN	375MG	TABLET / ORAL	AB	1993-12-21	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074140-003	NAPROXEN	500MG	TABLET / ORAL	AB	1993-12-21	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A074140-001	NAPROXEN	250MG	TABLET / ORAL	AB	1993-12-21	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 102 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A074140-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074140-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A074140-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074140-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074140-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A074140-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A074140-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074140-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A074140-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074140-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074140-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A074140-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074140-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074140-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A074140-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074140-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074140-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A074140-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074140-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074140-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A074140-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074140-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074140-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A074140-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074140-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074140-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A074140-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A074140-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074140-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A074140-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074140-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074140-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A074140-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074140-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074140-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A074140-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074140-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074140-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A074140-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A074140-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: Naproxen
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
NAPROXEN	500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
57Y76R9ATQ	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
198014	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
fb07a76b-98ce-85dd-e053-6294a90aa6a8	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fef6ad89-235f-4274-ba49-a8e53642473e	Product name	2	20250225
87fed3e6-8fba-48ef-96b0-3a7fb54b96ff	Product name	3	20230306
b5fdaaec-7251-4da6-9cb2-4e9e76939ec8	Product name	1	20200623
e76dbbc1-775d-722c-08ff-ed45e8a80def	Product name	3	20181002
6f4f4521-fd56-1ae6-888b-3b021bd75c7c	Product name	1	20140508
ce67e27d-1d21-5465-4409-b0662dd99d4d	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
51655-457-20	2025-04-10	These highlights do not include all the information needed to use NAPROXEN TABLETS, safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976
51655-457-25	2025-04-10	These highlights do not include all the information needed to use NAPROXEN TABLETS, safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976
51655-457-26	2025-04-10	These highlights do not include all the information needed to use NAPROXEN TABLETS, safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976
51655-457-52	2025-04-10	These highlights do not include all the information needed to use NAPROXEN TABLETS, safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976
51655-457-20	2025-01-30	These highlights do not include all the information needed to use NAPROXEN TABLETS, safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976
51655-457-25	2025-01-30	These highlights do not include all the information needed to use NAPROXEN TABLETS, safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976
51655-457-26	2025-01-30	These highlights do not include all the information needed to use NAPROXEN TABLETS, safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976
51655-457-52	2025-01-30	These highlights do not include all the information needed to use NAPROXEN TABLETS, safely and effectively. See full prescribing information for NAPROXEN TABLETS. NAPROXEN tablets, for oral use Initial U.S. Approval: 1976

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
51655-457-20	Naproxen	20 in 1 BOTTLE, PLASTIC	TABLET	20	4
51655-457-25	Naproxen	60 in 1 BOTTLE, PLASTIC	TABLET	60	4
51655-457-26	Naproxen	90 in 1 BOTTLE, PLASTIC	TABLET	90	4
51655-457-52	Naproxen	30 in 1 BOTTLE, PLASTIC	TABLET	30	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51655-457	NAPROXEN TABLET [NORTHWIND PHARMACEUTICALS, LLC]	3	Current NDC, 4 package rows	20250410_fb07a76b-98ce-85dd-e053-6294a90aa6a8.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Naproxen	NAPROXEN	Redpharm Drug	52503536-593e-808b-e063-6294a90a737f	2026-05-21	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074140 application number: ANDA074140
Naproxen	NAPROXEN	REMEDYREPACK INC.	12202ef3-c65e-45a6-88ed-5d945d8fd41c	2026-04-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074140 application number: ANDA074140
Naproxen	NAPROXEN	Northwind Health Company, LLC	0de6d673-fa76-e9c0-e063-6394a90a9ded	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074140 application number: ANDA074140
Naproxen	NAPROXEN	Northwind Health Company, LLC	fb07a76b-98ce-85dd-e053-6294a90aa6a8	2026-01-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074140 application number: ANDA074140 ndc (product): 51655-457
Naproxen	NAPROXEN	Granules Pharmaceuticals Inc.	c1cb9bb9-fbae-5e5c-e053-2995a90a0d21	2025-12-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074140 application number: ANDA074140
Naproxen	NAPROXEN SODIUM	Granules India Ltd	1f8da545-bcfe-4c22-a9f1-d34108120aa0	2025-12-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074140 application number: ANDA074140
Naproxen	NAPROXEN	REMEDYREPACK INC.	e519fa49-5bd9-405c-a7fb-1403edb8976b	2025-11-03	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 074140 application number: ANDA074140

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
57Y76R9ATQ	NAPROXEN	22204-53-1	NAPROXEN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
198014	naproxen 500 MG Oral Tablet	PSN	fb07a76b-98ce-85dd-e053-6294a90aa6a8	4
198014	naproxen 500 MG Oral Tablet	SCD	fb07a76b-98ce-85dd-e053-6294a90aa6a8	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
51655-457-20	51655045720	20 TABLET in 1 BOTTLE, PLASTIC (51655-457-20)	20 tablet	2023-07-03	No	No	Current
51655-457-25	51655045725	60 TABLET in 1 BOTTLE, PLASTIC (51655-457-25)	60 tablet	2023-05-04	No	No	Current
51655-457-26	51655045726	90 TABLET in 1 BOTTLE, PLASTIC (51655-457-26)	90 tablet	2023-06-15	No	No	Current
51655-457-52	51655045752	30 TABLET in 1 BOTTLE, PLASTIC (51655-457-52)	30 tablet	2023-05-04	No	No	Current